REMINDER – Questionnaire Responses Due to the U.S. International Trade Commission by February 6th
Responses to the fishermen/farmers and processors questionnaires issued by the U.S. International Trade Commission (“Commission”) in the third sunset review of the antidumping duty orders on frozen warmwater shrimp from China, India, Thailand, and Vietnam are due to the Commission no later than February 6, 2023. The responses to these questionnaires will be analyzed by the Commission to determine whether […]
Filed Under
$340k in CDSOA Funds Distributed to Shrimp Industry in FY2022
Last week, U.S. Customs and Border Protection (CBP) published information regarding the annual distribution under the Continued Dumping and Subsidy Offset Act (CDSOA) for fiscal year (FY) 2022. In total, CBP reports that $339,684.11 in antidumping duties collected on shrimp imports was distributed through the CDSOA program this year. This represents a significant increase from the $57,768.45 in antidumping duties collected on […]
Filed Under
International Trade Commission Issues Adequacy Determination, Votes to Conduct Full Sunset Reviews of Antidumping Duty Orders on Chinese, Indian, Thai, and Vietnamese Shrimp
On Friday, the five Commissioners currently sitting on the U.S. International Trade Commission (“Commission”) voted unanimously that the submissions by the U.S. domestic shrimp industry in response to the notice of institution of the third sunset reviews of the antidumping duty orders on certain frozen warmwater shrimp from China, India, Thailand, and Vietnam were “adequate,” meaning that they had met […]
Filed Under
GAO Report Questions FDA’s Import Alert Removal Process and Criticizes the Lack of Federal Agency Cooperation to Address Evasion
Last week, the U.S. Government Accountability Office (“GAO”) publicly released a report of its audit of the U.S. Food and Drug Administration’s (“FDA”) management of import alerts covering seafood – Imported Seafood Safety: Actions Needed to Improve FDA Oversight of Import Alert Removal Decisions (GAO-20-62, Nov. 2019). The GAO’s new report raises two major concerns regarding the FDA’s oversight of seafood […]